Cargando…
Proteoglycans—Biomarkers and Targets in Cancer Therapy
Proteoglycans (PGs), important constituents of the extracellular matrix, have been associated with cancer pathogenesis. Their unique structure consisting of a protein core and glycosaminoglycan chains endowed with fine modifications constitutes these molecules as capable cellular effectors important...
Autores principales: | Nikitovic, Dragana, Berdiaki, Aikaterini, Spyridaki, Ioanna, Krasanakis, Theodoros, Tsatsakis, Aristidis, Tzanakakis, George N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845539/ https://www.ncbi.nlm.nih.gov/pubmed/29559954 http://dx.doi.org/10.3389/fendo.2018.00069 |
Ejemplares similares
-
Proteoglycans in the Pathogenesis of Hormone-Dependent Cancers: Mediators and Effectors
por: Tzanakakis, George, et al.
Publicado: (2020) -
Proteoglycans and Immunobiology of Cancer—Therapeutic Implications
por: Tzanakakis, George, et al.
Publicado: (2019) -
Lumican mediates HTB94 chondrosarcoma cell growth via an IGF-IR/Erk1/2 axis
por: Papoutsidakis, Antonis, et al.
Publicado: (2020) -
The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis
por: Tzanakakis, George N., et al.
Publicado: (2021) -
Cancer Microenvironment and Inflammation: Role of Hyaluronan
por: Nikitovic, Dragana, et al.
Publicado: (2015)